-+ 0.00%
-+ 0.00%
-+ 0.00%
HCW Biologics signed an exclusive distribution agreement with Akron Biotech to commercialize HCW11-006 as a reagent to support the production of highly functional human CAR-T cells.
Share
Listen to the news
HCW Biologics signed an exclusive distribution agreement with Akron Biotech to commercialize HCW11-006 as a reagent to support the production of highly functional human CAR-T cells.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending